JPRN-UMIN000014450已完成4 期
Study about the efficacy of lorazepam as a premedication for the disabled patients showing serious maladaptive behaviors in dentistry - The efficacy of lorazepam for the intellectually disabled patients
Ogata Pediatric Dental Clinic0 个研究点目标入组 50 人开始时间: 2014年7月2日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12years-old 至 45years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Subjects who are contraindicated to benzodiazepine drugs (acute narrow-angle glaucoma, nuero-muscle disease). 2)Consultation is needed about an indication of lorazepam, to a regular doctor if a subject is administered other psychotropic drugs.
研究者
相似试验
已完成
3 期
Lorazepam for the Treatment of Status Epilepticus or Repetitive Status Epilepticus in JapanStatus EpilepticusNCT02239380Pfizer26
进行中（未招募）
不适用
Investigation of the effectiveness of oral lorazepam in managing preoperative dental anxiety in phobic dental patients-A pilot study - Oral lorazepam for managing dental anxiety.Pre operative dental anxiety, in phobic dental patients.EUCTR2005-003749-15-GBMerck, Sharp & Dohme-Clinical Pharmacology,Europe36
已完成
2 期
orazepam effect on reducing nausea and vomitingHyperemesis gravidarum.Hyperemesis gravidarum with metabolic disturbanceIRCT2014051917742N2Vice chancellor for research Ahvaz Jundishapur University of Medical Sciences76
已完成
1 期
Phase 1 Study to Characterize the Safety and Pharmacokinetics of Single Intravenous Dose of Lorazepam in Healthy Japanese Adult SubjectsHealthyNCT01994668Pfizer8
进行中（未招募）
1 期
A study to assess the effectiveness of esomeprazole 40 mg once daily in subjects with continuing gastroesophageal reflux disease (GORD) symptoms following treatment with a previous full dose proton pump inhibitor (PPI). An 8 week, open label, multicentre study. - RESPONSE studyGastroesophageal Reflux Disease (GORD)EUCTR2006-000257-22-GBAstraZeneca UK Ltd100